Tirzepatide 0.5mg ODT — 30ct
Compounded tirzepatide dual GIP/GLP-1 oral dissolving tablet, starter dose.
- Strength
- 0.5mg/tablet
- Size
- 30 Tablets
- Format
- odt
- Price
- $85
These products are intended for research and educational purposes only. They have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption. Read full disclaimer
Description
What is Tirzepatide?
Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist — a newer generation of weight management peptide that targets two metabolic pathways simultaneously. Where semaglutide activates one receptor, tirzepatide activates two, offering a distinct physiological profile that has shown strong results in clinical research.
How It Works
By engaging both GIP and GLP-1 receptors, tirzepatide addresses appetite regulation, insulin sensitivity, and metabolic rate in a complementary way. GIP receptors are involved in fat metabolism and energy storage, while GLP-1 receptors manage appetite signaling and gastric emptying. Activating both pathways together appears to produce a synergistic effect on body weight and metabolic function beyond what either pathway achieves alone.
Key Benefits
Phase 3 clinical trials for tirzepatide (the SURMOUNT program) reported average weight reductions of 15–22% of body weight — results that outperformed prior GLP-1 therapies in head-to-head comparisons. Participants also showed improvements in blood sugar control, triglyceride levels, and blood pressure. It is available as a weekly injectable and as an orally disintegrating tablet (ODT) for oral administration.
What to Expect
Tirzepatide protocols typically start at a low dose with gradual weekly escalation. The dual-receptor mechanism means appetite suppression can be more pronounced than with single-agonist therapies. Most patients notice reduced hunger and improved satiety within the first 4 weeks. Gastrointestinal side effects are possible during dose titration and tend to decrease as the body adjusts.
Quality & Sourcing
Every tirzepatide formulation from Greenstone Peptides is compounded in the USA by licensed pharmacy partners under USP 797 sterile standards. Each batch is third-party tested for potency, sterility, and endotoxin.